Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel treatment strategies for cancer covered in recent patent literature

Aug. 17, 2006

Recent Janssen and Taiho patents describe new compounds for urological disorders

Aug. 16, 2006

Recent patents reveal novel agents for treating endocrine-related disorders

Aug. 16, 2006

New antiinfective agents reported in recent patent literature

Aug. 16, 2006

Novel P2Y1 receptor antagonists for thrombotic disorders emerge from Bristol-Myers Squibb R&D

Aug. 14, 2006

Novel therapeutic agents for respiratory disorders disclosed in recent patents

Aug. 14, 2006

New therapeutic agents for metabolic disorders reported in recent patent literature

Aug. 14, 2006

New chemokine receptor ligands for HIV reported in recent GSK patent

Aug. 10, 2006

Novel anti-HCV agents reported in recent Genelabs patent

Aug. 10, 2006

Recent patents cover therapeutic agents for neurological disorders

Aug. 10, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.